|
1
|
Braunwald E: The war against heart
failure: The Lancet lecture. Lancet. 385:812–824. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gajarsa JJ and Kloner RA: Left ventricular
remodeling in the post-infarction heart: A review of cellular,
molecular mechanisms, and therapeutic modalities. Heart Fail Rev.
16:13–21. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Koitabashi N and Kass DA: Reverse
remodeling in heart failure - mechanisms and therapeutic
opportunities. Nat Rev Cardiol. 9:147–157. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tilemann L, Ishikawa K, Weber T and Hajjar
RJ: Gene therapy for heart failure. Circ Res. 110:777–793. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ding L, Dong L, Chen X, Zhang L, Xu X,
Ferro A and Xu B: Increased expression of integrin-linked kinase
attenuates left ventricular remodeling and improves cardiac
function after myocardial infarction. Circulation. 120:764–773.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hannigan GE, Leung-Hagesteijn C,
Fitz-Gibbon L, Coppolino MG, Radeva G, Filmus J, Bell JC and Dedhar
S: Regulation of cell adhesion and anchorage-dependent growth by a
new beta 1-integrin-linked protein kinase. Nature. 379:91–96. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Knöll R, Postel R, Wang J, Krätzner R,
Hennecke G, Vacaru AM, Vakeel P, Schubert C, Murthy K, Rana BK, et
al: Laminin-alpha4 and integrin-linked kinase mutations cause human
cardiomyopathy via simultaneous defects in cardiomyocytes and
endothelial cells. Circulation. 116:515–525. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
White DE, Coutu P, Shi YF, Tardif JC,
Nattel S, St Arnaud R, Dedhar S and Muller WJ: Targeted ablation of
ILK from the murine heart results in dilated cardiomyopathy and
spontaneous heart failure. Genes Dev. 20:2355–2360. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lee SP, Youn SW, Cho HJ, Li L, Kim TY,
Yook HS, Chung JW, Hur J, Yoon CH, Park KW, et al: Integrin-linked
kinase, a hypoxia-responsive molecule, controls postnatal
vasculogenesis by recruitment of endothelial progenitor cells to
ischemic tissue. Circulation. 114:150–159. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ling L, Bai J, Gu R, Jiang C, Li R, Kang
L, Ferro A and Xu B: Sca-1+ cardiac progenitor cell
therapy with cells overexpressing integrin-linked kinase improves
cardiac function after myocardial infarction. Transplantation.
95:1187–1196. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mao Q, Lin C, Gao J, Liang X, Gao W, Shen
L, Kang L and Xu B: Mesenchymal stem cells overexpressing
integrin-linked kinase attenuate left ventricular remodeling and
improve cardiac function after myocardial infarction. Mol Cell
Biochem. 397:203–214. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hendel RC, Berman DS, Di Carli MF,
Heidenreich PA, Henkin RE, Pellikka PA, Pohost GM and Williams KA:
American College of Cardiology Foundation Appropriate Use Criteria
Task Force; American Society of Nuclear Cardiology; American
College of Radiology; American Heart Association; American Society
of Echocardiology; Society of Cardiovascular Computed Tomography;
Society for Cardiovascular Magnetic Resonance; Society of Nuclear
Medicine: ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 appropriate use
criteria for cardiac radionuclide imaging: A report of the American
College of Cardiology Foundation appropriate use criteria task
force, the American Society of Nuclear Cardiology, the American
College of Radiology, the American Heart Association, the American
Society of Echocardiography, the Society of Cardiovascular Computed
Tomography, the Society for Cardiovascular Magnetic Resonance, and
the Society of Nuclear Medicine. J Am Coll Cardiol. 53:2201–2229.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rutanen J, Rissanen TT, Markkanen JE,
Gruchala M, Silvennoinen P, Kivelä A, Hedman A, Hedman M, Heikura
T, Ordén MR, et al: Adenoviral catheter-mediated intramyocardial
gene transfer using the mature form of vascular endothelial growth
factor-D induces transmural angiogenesis in porcine heart.
Circulation. 109:1029–1035. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kawase Y, Ly HQ, Prunier F, Lebeche D, Shi
Y, Jin H, Hadri L, Yoneyama R, Hoshino K, Takewa Y, et al: Reversal
of cardiac dysfunction after long-term expression of SERCA2a by
gene transfer in a pre-clinical model of heart failure. J Am Coll
Cardiol. 51:1112–1119. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Thygesen K, Alpert JS, Jaffe AS, Simoons
ML, Chaitman BR and White HD: Writing Group on behalf of the Joint
ESC/ACCF/AHA/WHF Task Force for the Universal Definition of
Myocardial Infarction: Third universal definition of myocardial
infarction. Glob Heart. 7:275–295. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Flotats A, Knuuti J, Gutberlet M, Marcassa
C, Bengel FM, Kaufmann PA, Rees MR and Hesse B: Cardiovascular
Committee of the EANM, the ESCR and the ECNC: Hybrid cardiac
imaging: SPECT/CT and PET/CT. A joint position statement by the
European Association of Nuclear Medicine (EANM), the European
Society of Cardiac Radiology (ESCR) and the European Council of
Nuclear Cardiology (ECNC). Eur J Nucl Med Mol Imaging. 38:201–212.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sutton MG and Sharpe N: Left ventricular
remodeling after myocardial infarction: Pathophysiology and
therapy. Circulation. 101:2981–2988. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Scimia MC, Gumpert AM and Koch WJ:
Cardiovascular gene therapy for myocardial infarction. Expert Opin
Biol Ther. 14:183–195. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
O'Gara PT, Kushner FG, Ascheim DD, Casey
DE Jr, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM,
Franklin BA, et al: CF/AHA Task Force: 2013 ACCF/AHA guideline for
the management of ST-elevation myocardial infarction: executive
summary: a report of the American College of Cardiology
Foundation/American Heart Association Task Force on Practice
Guidelines. Circulation. 127:529–555. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hajjar RJ: Potential of gene therapy as a
treatment for heart failure. J Clin Invest. 123:53–61. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Vejpongsa P and Yeh ETH: Wrestling with
heart failure: SUMO-1 to the rescue. Circ Res. 114:1561–1563. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tilemann L, Lee A, Ishikawa K, Aguero J,
Rapti K, Santos-Gallego C, Kohlbrenner E, Fish KM, Kho C and Hajjar
RJ: SUMO-1 gene transfer improves cardiac function in a
large-animal model of heart failure. Sci Transl Med.
5:211ra1592013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zsebo K, Yaroshinsky A, Rudy JJ, Wagner K,
Greenberg B, Jessup M and Hajjar RJ: Long-term effects of
AAV1/SERCA2a gene transfer in patients with severe heart failure:
Analysis of recurrent cardiovascular events and mortality. Circ
Res. 114:101–108. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Greenberg B, Yaroshinsky A, Zsebo KM,
Butler J, Felker GM, Voors AA, Rudy JJ, Wagner K and Hajjar RJ:
Design of a phase 2b trial of intracoronary administration of
AAV1/SERCA2a in patients with advanced heart failure: The CUPID 2
trial (calcium up-regulation by percutaneous administration of gene
therapy in cardiac disease phase 2b). JACC Heart Fail. 2:84–92.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Traister A, Li M, Aafaqi S, Lu M, Arab S,
Radisic M, Gross G, Guido F, Sherret J, Verma S, et al:
Integrin-linked kinase mediates force transduction in
cardiomyocytes by modulating SERCA2a/PLN function. Nat Commun.
5:45332014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bock-Marquette I, Saxena A, White MD,
Dimaio JM and Srivastava D: Thymosin beta4 activates
integrin-linked kinase and promotes cardiac cell migration,
survival and cardiac repair. Nature. 432:466–472. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mao Q, Lin CX, Liang XL, Gao JS and Xu B:
Mesenchymal stem cells overexpressing integrin-linked kinase
attenuate cardiac fibroblast proliferation and collagen synthesis
through paracrine actions. Mol Med Rep. 7:1617–1623.
2013.PubMed/NCBI
|
|
28
|
Nho RS, Xia H, Kahm J, Kleidon J, Diebold
D and Henke CA: Role of integrin-linked kinase in regulating
phosphorylation of Akt and fibroblast survival in type I collagen
matrices through a beta1 integrin viability signaling pathway. J
Biol Chem. 280:26630–26639. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ding L, Dong L, Chen X, Zhang L, Xu X,
Ferro A and Xu B: Increased expression of integrin-linked kinase
attenuates left ventricular remodeling and improves cardiac
function after myocardial infarction. Circulation. 120:764–773.
2009. View Article : Google Scholar : PubMed/NCBI
|
